A Phase 1, Open-Label, Multicenter, Dose Escalation Study of mRNA 2752, a Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L, IL-23, and IL-36γ, for Intratumoral Injection Alone and in Combination with Immune Checkpoint Blockade

January 16, 2019
Solid Tumors
Principal Investigator: unassigned
Solid Tumor, Breast, Head, Neck, Lymphoma, Melanoma
Accepting Participants